Cargando…
Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway
OBJECTIVES: Recently, immunotherapy and microRNA have shown much more promises in oncology research, inspiring new hope for a cure for various malignancies. Specifically, the function and mechanisms of action of pembrolizumab have been investigated in many cancers, but not in laryngeal squamous cell...
Autores principales: | Chen, Hui, Guo, Yang, Huang, Jiameng, Zhou, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997759/ https://www.ncbi.nlm.nih.gov/pubmed/33791361 http://dx.doi.org/10.1155/2021/2342784 |
Ejemplares similares
-
miR-23a binds to p53 and enhances its association with miR-128 promoter
por: Li, Jincheng, et al.
Publicado: (2015) -
Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018) -
Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation
por: Zheng, Tianying, et al.
Publicado: (2022) -
The Role of miR-128 in Neurodegenerative Diseases
por: Lanza, Marika, et al.
Publicado: (2023) -
LncRNA-IUR Sponges miR-24 to Upregulate P53 in Laryngeal Squamous Cell Carcinoma
por: Wei, Cen, et al.
Publicado: (2020)